Cytosorbents Corp Stock OTC Bulletin Board
Stocks
US23283X2062
Advanced Medical Equipment & Technology
|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 05-14 | Cytosorbents Corporation, Q1 2026 Earnings Call, May 13, 2026 | |
| 05-14 | Cytosorbents Corporation Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| Market Cap | 27M 23.63M 21.78M 20.18M 38.32M 2.56B 38.93M 261M 102M 1.26B 101M 99.18M 4.37B | P/E 2026 * |
-2.32x | P/E 2027 * | 14.3x |
|---|---|---|---|---|---|
| Enterprise Value | 27M 23.63M 21.78M 20.18M 38.32M 2.56B 38.93M 261M 102M 1.26B 101M 99.18M 4.37B | EV / Sales 2026 * |
0.71x | EV / Sales 2027 * | 0.57x |
| Free-Float |
84.28% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Cytosorbents Corp
| Manager | Title | Age | Since |
|---|---|---|---|
Phillip Chan
CEO | Chief Executive Officer | 55 | 24/07/2008 |
Peter Mariani
DFI | Director of Finance/CFO | 62 | 14/08/2024 |
Vincent Capponi
PSD | President | 68 | 28/04/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
Edward Jones
BRD | Director/Board Member | 77 | 25/07/2011 |
Phillip Chan
BRD | Director/Board Member | 55 | 01/01/2009 |
Alan Sobel
BRD | Director/Board Member | 65 | 13/11/2014 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.72% | +2.66% | +22.92% | +0.18% | 192B | |
| -1.37% | +7.28% | -20.21% | +28.78% | 153B | |
| +0.06% | +1.64% | -3.02% | -16.94% | 137B | |
| +1.63% | +5.89% | -56.47% | -13.57% | 66.29B | |
| -0.37% | +4.91% | +23.74% | +5.14% | 54.8B | |
| +1.06% | +3.07% | -24.36% | -28.90% | 44.44B | |
| -0.94% | -0.08% | +8.08% | +41.86% | 37.2B | |
| -0.15% | -1.90% | +9.27% | +11.38% | 36.89B | |
| +0.08% | +12.19% | -14.73% | +1.32% | 31.5B | |
| Average | -0.08% | +3.01% | -6.09% | +3.25% | 83.76B | |
| Weighted average by Cap. | -0.32% | +3.29% | -3.25% | +2.97% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 38.26M 33.48M 30.86M 28.6M 54.3M 3.63B 55.17M 370M 144M 1.79B 144M 141M 6.19B | 47.12M 41.24M 38M 35.23M 66.87M 4.47B 67.95M 456M 177M 2.21B 177M 173M 7.63B |
| Net income | -11.74M -10.27M -9.47M -8.78M -16.66M -1.11B -16.93M -114M -44.15M -550M -44.08M -43.12M -1.9B | 2.37M 2.08M 1.91M 1.77M 3.37M 225M 3.42M 22.95M 8.92M 111M 8.91M 8.72M 384M |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
